Cancer drug development forum
Multi-stakeholder discussion platform in oncology
Accelerating the development and delivery of effective oncology treatments to patients
Our mission is to unite stakeholders across science, regulation, and policy to remove barriers in oncology drug development and turn complex challenges into practical solutions.
Our vision is a world where every cancer patient has timely access to the most effective, innovative treatments.
Patients
Patients are at the heart of CDDF’s mission. We actively involve patients and advocacy groups in our multi-stakeholder dialogue. Explore opportunities to collaborate and access available grants.
Academia
CDDF empowers academic researchers to share expertise and drive innovation in cancer drug development. Join our discussions and explore ways to contribute.
Regulators and HTA agencies
CDDF brings together regulators and HTA agencies to exchange insights on critical oncology topics. Stay informed, engage in dialogue, and explore collaboration opportunities.
industry
CDDF offers the healthcare industry a unique platform to collaborate and accelerate oncology drug development. Join our Industry Membership Program and connect with leading experts.
News !
Executive Summary: CDDF & AAADV Workshop – Challenges in the Landscape of a Global Development Strategy Including Patient Access (30-31 March 2026, BE)
The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of...
![[News from ACT EU] – Clinical Trials Information System (CTIS): training and support](https://cddf.org/wp-content/uploads/2026/04/Copy-of-PUBLICATION-Annual-Repport-2024-Is-available-4-400x250.jpg)
[News from ACT EU] – Clinical Trials Information System (CTIS): training and support
Check out the publication of a new EMA document of frequently asked questions (FAQ) for sponsors...
Upcoming events!
CDDF Diversity Initiative
The CDDF Diversity Initiative is a multi-stakeholder project advancing diversity in oncology clinical research. It defines relevant population descriptors, reviews existing evidence, and explores how diversity data can be integrated into trial analysis. The work will result in a consensus white paper to guide more inclusive clinical trials and improve outcomes for patients across Europe.
Our Sustainability Efforts
Sustainability is a core value in the way we work. We actively promote eco-friendly practices such as using greener delivery and transportation options, re-using event badges and materials, and encouraging remote activities to reduce unnecessary travel. These small but important steps help us minimize our environmental footprint while supporting a more responsible way of working.
For more details on our initiatives, please click on the picture to view the brochure.
Subscribe to Stay Connected